Eiger BioPharmaceuticals, Inc.
Treatment of hepatitis delta virus infection

Last updated:

Abstract:

Methods of reducing hepatitis delta virus (HDV) viral loads in a patient are provided. In some embodiments, the method comprises treating the patient with lonafarnib-ritonavir co-therapy. In some embodiments, the method further comprises treating the patient with an interferon.

Status:
Grant
Type:

Utility

Filling date:

1 Aug 2018

Issue date:

10 Nov 2020